Immunotherapeutic restoration in HIV-infected individuals.
about
Anti-HIV-1 nanotherapeutics: promises and challenges for the futureMicrodevices for examining immunological responses of single cells to HIVA randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection.Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
P2860
Immunotherapeutic restoration in HIV-infected individuals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunotherapeutic restoration in HIV-infected individuals.
@en
Immunotherapeutic restoration in HIV-infected individuals.
@nl
type
label
Immunotherapeutic restoration in HIV-infected individuals.
@en
Immunotherapeutic restoration in HIV-infected individuals.
@nl
prefLabel
Immunotherapeutic restoration in HIV-infected individuals.
@en
Immunotherapeutic restoration in HIV-infected individuals.
@nl
P2860
P356
P1433
P1476
Immunotherapeutic restoration in HIV-infected individuals.
@en
P2093
June Myung Kim
Sang Hoon Han
P2860
P304
P356
10.2217/IMT.10.91
P577
2011-02-01T00:00:00Z